Diabetes Mellitus clinical trials

Explore recruiting diabetes mellitus clinical trials.

Recruiting diabetes mellitus studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Diabetes Mellitus trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

NT-proBNP Selected PreventiOn of cardiac eveNts in a populaTion of dIabetic patients without A history of Cardiac disease; a prospective randomized trial

Spain, Austria

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 1/2 Study to Evaluate the Safety, Tolerability, and Efficacy of VX-264 in Subjects With Type 1 Diabetes Mellitus

Netherlands, Germany, Italy

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Platelet function testing in outpatients after heart transplantation on aspirin therapy

Austria

Therapeutic use (Phase IV) EU CTIS Study details

SGL-TX-PTDM: SGLT2i effect on PTDM development and kidney allograft function in kidney transplant recipients: A randomized, double-blind, placebo controlled, national multicenter trial

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

DAPARHT: DAPAgliflozin for Renal protection in Heart Transplant recipients

Netherlands, Norway, Sweden

Therapeutic confirmatory (Phase III) EU CTIS Study details

Prospective study to assess with Continuous Glucose Monitoring (CGM) the efficacy and safety of switching to insulin glargine 300 U/ml from insulin glargine 100 U/ml in Type 2 Diabetes (T2DM) patients with renal impairment

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Diabetes Mellitus trials by city

Diabetes Mellitus in Toronto Diabetes Mellitus in Vancouver Diabetes Mellitus in Montreal Diabetes Mellitus in Calgary Diabetes Mellitus in Edmonton Diabetes Mellitus in Ottawa Diabetes Mellitus in Winnipeg Diabetes Mellitus in Quebec City Diabetes Mellitus in Hamilton Diabetes Mellitus in Kitchener Diabetes Mellitus in London Diabetes Mellitus in Halifax Diabetes Mellitus in New York Diabetes Mellitus in Los Angeles Diabetes Mellitus in Chicago Diabetes Mellitus in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease